Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 785 across all filing types
Latest filing 2020-07-03 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions for the month ended 30/06/2020. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. This type of document is a regulatory filing related to share capital movements and is typically submitted to the exchange as a compliance requirement. It does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update, which would involve broader financial data or fundraising activities. Given the detailed share capital movement data and the regulatory submission context, the most appropriate classification is Regulatory Filings (RNS), which serves as a general category for compliance and regulatory announcements that do not fit other specific categories.
2020-07-03 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 16, 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on June 16, 2020. It details the voting outcomes on various resolutions including adoption of financial statements, re-election of directors, appointment of auditors, and mandates for share repurchase and issuance. The document does not contain the full AGM materials or presentations, nor is it the full annual report or financial statements. It is a formal announcement of voting results from the AGM, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5,236 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is DVA with high confidence.
2020-06-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/05/2020. The content focuses on share capital changes, share options, and related securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly equity movements, not a full annual or interim report, earnings release, or management discussion. The document is comprehensive and contains substantive data on share capital changes, fitting the category of a regulatory announcement on capital changes. Given the detailed nature of share capital movements and the monthly frequency, the best fitting category is 'Share Issue/Capital Change' (SHA).
2020-06-02 English
UNAUDITED RESULTS FOR THE FIRST QUARTER OF 2020 OF CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
Earnings Release Classification · 95% confidence The document is an announcement by PW Medtech Group Limited regarding the unaudited financial results of its associate, China Biologic Products Holdings, Inc. (CBPO), for the first quarter of 2020. It references an Earnings Release filed by CBPO with the SEC and provides a summary of key financial figures from that release. The document itself is relatively short (4002 characters) and primarily serves to inform shareholders and investors about the associate's financial results, with a link to the full Earnings Release. It does not contain the full financial statements or detailed analysis but rather summarizes and points to the original earnings release. According to the 'Menu vs Meal' rule, this is an announcement of an earnings release rather than the earnings release itself. Therefore, the appropriate classification is Earnings Release (ER). The confidence is high given the clear reference to the earnings release and summary financial data. Q1 2020
2020-05-21 English
COMPLETION OF MAJOR TRANSACTION DISPOSAL OF CBPO SHARES
Capital/Financing Update Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the completion of a major transaction involving the disposal of shares in CBPO. It references previous announcements and a circular related to the disposal, states the completion date, and details the use of proceeds to repay a loan. The document is relatively short (2169 characters) and serves as a formal announcement of the completion of a transaction rather than a detailed report or financial statement. This fits the category of a Capital/Financing Update (CAP), as it provides an update on a significant financing-related transaction and capital structure change.
2020-05-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 30/04/2020. The content focuses on changes in share capital and securities, including share options and warrants, without any financial performance data or earnings information. This type of document is a regulatory filing reporting share capital movements and is not a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive data. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-05-07 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.